Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (281-290 of 310) with videos related to

Pageof 31
Sort By:
Frontiers in Immunology|November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Plos One|September 1, 2012
A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological resultsPhilippe H Lagrange, Satheesh K Thangaraj, Rajeshwar Dayal, et al.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
The European Respiratory Journal|November 1, 2014
False-negative interferon-γ release assay results in active tuberculosis: a TBNET studyVeerle de Visser, Giovanni Sotgiu, Christoph Lange, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
Neurology|November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying TherapiesCarla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
The European Respiratory Journal|August 27, 2021
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global studyGiovanni Battista Migliori, Pei Min Thong, Jan-Willem Alffenaar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 17, 2025
Mycobacterium tuberculosis-specific blood immune signatures distinguish sarcoidosis from tuberculosis diseaseLeila Y Chihab, Catherine Cheng, Hannah Hillman, et al.
Vaccines|November 25, 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 VaccineAndrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2015
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group StudyJean-Pierre Zellweger, Giovanni Sotgiu, Michael Block, et al.
Pageof 31

Showing results (281-290 of 310) with videos related to

Sort By:
Pageof 31
Frontiers in Immunology|November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Plos One|September 1, 2012
A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological resultsPhilippe H Lagrange, Satheesh K Thangaraj, Rajeshwar Dayal, et al.
Bulletin of the World Health Organization|November 14, 2023
Target product profiles: tests for tuberculosis treatment monitoring and optimizationAnkur Gupta-Wright, Saskia den Boon, Emily L MacLean, et al.
The European Respiratory Journal|November 1, 2014
False-negative interferon-γ release assay results in active tuberculosis: a TBNET studyVeerle de Visser, Giovanni Sotgiu, Christoph Lange, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
Neurology|November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying TherapiesCarla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
The European Respiratory Journal|August 27, 2021
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global studyGiovanni Battista Migliori, Pei Min Thong, Jan-Willem Alffenaar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 17, 2025
Mycobacterium tuberculosis-specific blood immune signatures distinguish sarcoidosis from tuberculosis diseaseLeila Y Chihab, Catherine Cheng, Hannah Hillman, et al.
Vaccines|November 25, 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 VaccineAndrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2015
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group StudyJean-Pierre Zellweger, Giovanni Sotgiu, Michael Block, et al.
Pageof 31